Sanofi allergy drug safe enough for non-prescription use: FDA reviewers
WASHINGTON (Reuters) - Sanofi SA's allergy drug Nasacort AQ is safe enough to be sold over the counter, according to reviewers for the U.S. Food and Drug Administration.
The reviewers, whose opinions were posted on Monday on the FDA's website, said the nasal spray, which currently requires a prescription for use, "has a favorable risk-benefit profile" for use in an over-the-counter setting.
The documents were posted ahead of a meeting on Wednesday of an advisory committee to the FDA which will recommend whether or not the agency should approve the switch to over-the-counter use. The drug is used to treat hay fever and other respiratory allergies.
(Reporting by Toni Clarke in Washington; Editing by Gerald E. McCormick)
- Washington, DC city council raises minimum wage to $11.50/hr in 2016
- India removes barriers to U.S. embassy as anger grows over diplomat's arrest
- Winning ticket sold in California for Mega Millions lottery: official
- UPDATE 5-Mega Millions lottery winning tickets sold in California, Georgia -Officials
- U.N. told up to 500 killed in South Sudan clashes: diplomats